Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    August 2017
  1. KODAMA M, Kodama T, Newberg JY, Katayama H, et al
    In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
    Proc Natl Acad Sci U S A. 2017 Aug 15. pii: 201705441.
    PubMed     Text format     Abstract available


    January 2017
  2. TANG Z, Steranka JP, Ma S, Grivainis M, et al
    Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201619797.
    PubMed     Text format     Abstract available


    May 2016
  3. KRIMMEL JD, Schmitt MW, Harrell MI, Agnew KJ, et al
    Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues.
    Proc Natl Acad Sci U S A. 2016 May 5. pii: 201601311.
    PubMed     Text format     Abstract available


    April 2016
  4. MENGHI F, Inaki K, Woo X, Kumar PA, et al
    The tandem duplicator phenotype as a distinct genomic configuration in cancer.
    Proc Natl Acad Sci U S A. 2016;113:E2373-82.
    PubMed     Text format     Abstract available


  5. DANG X, Gu L, Qi J, Correa S, et al
    Layer-by-layer assembled fluorescent probes in the second near-infrared window for systemic delivery and detection of ovarian cancer.
    Proc Natl Acad Sci U S A. 2016 Apr 25. pii: 201521175.
    PubMed     Text format     Abstract available


    November 2015
  6. CHOI YJ, Ingram PN, Yang K, Coffman L, et al
    Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2.
    Proc Natl Acad Sci U S A. 2015 Nov 30. pii: 201507899.
    PubMed     Text format     Abstract available


  7. WANG R, Stone RL, Kaelber JT, Rochat RH, et al
    Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer.
    Proc Natl Acad Sci U S A. 2015;112:14266-14271.
    PubMed     Text format     Abstract available


    July 2015
  8. PEPIN D, Sosulski A, Zhang L, Wang D, et al
    AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
    Proc Natl Acad Sci U S A. 2015 Jul 27. pii: 201510604.
    PubMed     Text format     Abstract available


  9. HEARN JM, Romero-Canelon I, Munro AF, Fu Y, et al
    Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.
    Proc Natl Acad Sci U S A. 2015 Jul 10. pii: 201500925.
    PubMed     Text format     Abstract available


    June 2015
  10. SHATHASIVAM P, Kollara A, Ringuette MJ, Virtanen C, et al
    Human ortholog of Drosophila Melted impedes SMAD2 release from TGF-beta receptor I to inhibit TGF-beta signaling.
    Proc Natl Acad Sci U S A. 2015;112:E3000-9.
    PubMed     Text format     Abstract available


    May 2015
  11. BARRETT CL, DeBoever C, Jepsen K, Saenz CC, et al
    Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.
    Proc Natl Acad Sci U S A. 2015 May 26. pii: 201508057.
    PubMed     Text format     Abstract available


  12. ROTEM A, Janzer A, Izar B, Ji Z, et al
    Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation.
    Proc Natl Acad Sci U S A. 2015;112:5708-13.
    PubMed     Text format     Abstract available


    March 2015
  13. KANNAN K, Coarfa C, Chao PW, Luo L, et al
    Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.
    Proc Natl Acad Sci U S A. 2015;112:E1272-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: